MARKET

AKRX

AKRX

Akorn
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.350
-0.060
-4.26%
After Hours: 1.350 0 0.00% 16:30 01/17 EST
OPEN
1.450
PREV CLOSE
1.410
HIGH
1.490
LOW
1.330
VOLUME
2.22M
TURNOVER
--
52 WEEK HIGH
5.46
52 WEEK LOW
1.190
MARKET CAP
170.30M
P/E (TTM)
-0.4652
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AKRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AKRX News

  • Akorn, Inc. -- Moody's announces completion of a periodic review of ratings of Akorn, Inc.
  • Moody's.4d ago
  • The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
  • Benzinga.01/07 12:57
  • Akorn And Conn: High Risk And High Reward
  • Seeking Alpha - Article.01/02 19:44
  • The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe
  • Benzinga.01/02 13:52

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About AKRX

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
More

Webull offers Akorn, Inc. (AKRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.